MedicarePartD.guide

A non-government resource built from CMS public data

XGEVA 120 mg/1.7mL Injection

Also known as Denosumab. Coverage in Alaska (CMS PDP Region 34).

4 of 9 stand-alone Part D plans in Alaska cover this drug on tier 5.

4 of 4 plans apply a prior authorization, step therapy or quantity limit.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
HealthSpring Assurance Rx (PDP)$0.00/mo premium · $615.00 deductible5Specialty Tier25%—$2475.0700$4,950.142 units
  • Prior authorization
  • Quantity limit 1.7 per 28 days
Humana Basic Rx Plan (PDP)$0.00/mo premium · $615.00 deductible5Specialty Tier25%—$1973.6214$3,947.242 units
  • Prior authorization
  • Quantity limit 1.7 per 28 days
Humana Value Rx Plan (PDP)$10.60/mo premium · $601.00 deductible5Specialty Tier26%—$1973.6214$3,947.242 units
  • Prior authorization
  • Quantity limit 1.7 per 28 days
Humana Premier Rx Plan (PDP)$112.40/mo premium · $0.00 deductible5Specialty Tier33%—$1973.6214$3,947.242 units
  • Prior authorization
  • Quantity limit 1.7 per 28 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →